Janux Therapeutics
JANX
JANX
44 hedge funds and large institutions have $318M invested in Janux Therapeutics in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
22% less capital invested
Capital invested by funds: $407M → $318M (-$88.7M)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Holders
44
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4M | |
| 2 | +$1.82M | |
| 3 | +$1.05M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.02M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$601K |
Top Sellers
| 1 | -$2.58M | |
| 2 | -$628K | |
| 3 | -$254K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$191K |
| 5 |
D.E. Shaw & Co
New York
|
-$165K |